Clorox (CLX) Tops Q3 EPS by 9c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CLX Hot Sheet
Price: $99.37 +5.94%
Financial Fact:
Selling and administrative expenses: 200M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Selling and administrative expenses: 200M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q3 EPS of $1.64, $0.09 better than the analyst estimate of $1.55. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.67 billion.
GUIDANCE:
Clorox sees FY2026 EPS of $5.45-$5.65, versus the consensus of $5.86.
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
